NCT00140842

Brief Summary

This study will examine hormonal differences in ghrelin and growth hormone in obese and normal weight adolescents and their relationship to body composition and insulin resistance. The study will also investigate the effect of the macronutrient composition of a meal on postprandial ghrelin levels and whether ghrelin responses will predict the degree of hunger and caloric intake at a subsequent meal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2005

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2005

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 30, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 1, 2005

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2007

Completed
4.3 years until next milestone

Results Posted

Study results publicly available

September 2, 2011

Completed
Last Updated

November 2, 2021

Status Verified

October 1, 2021

Enrollment Period

2.1 years

First QC Date

August 30, 2005

Results QC Date

March 3, 2011

Last Update Submit

October 22, 2021

Conditions

Keywords

Obesity, adolescent, ghrelin, growth hormone, cortisol

Outcome Measures

Primary Outcomes (1)

  • Peak Growth Hormone (GH) on the GH Stimulation Test

    Peak growth hormone (GH) on the GH stimulation test is a measure of the adequacy of GH secretion.

    Baseline

Secondary Outcomes (1)

  • Visceral Adipose Tissue

    Baseline

Study Arms (2)

Obese girls

The inclusion criteria will be girls 12-18 years of age. According to the Centers for Disease Control and Prevention, the definition of obesity is a BMI higher than the 95th percentile for age and sex, and that of overweight is a BMI between the 85th and 95th percentiles. Cases will be defined as having a body mass index (BMI) greater than the 95th percentile for age according to the 2000 Centers for Disease Control and Prevention growth charts.

Normal-weight girls

Eligibility Criteria

Age12 Years - 18 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Obese and normal-weight girls between 12-18 years old

You may qualify if:

  • Girls 12-18 years of age
  • Obese subjects: BMI higher than the 95th percentile for age and sex
  • Normal-weight controls: BMI from the 15th to the 85th percentiles for age and sex

You may not qualify if:

  • History of disorders other than obesity that may affect growth hormone, ghrelin, cortisol, or insulin secretion such as eating disorder, diabetes mellitus, hypertension, thyroid disease, Cushing's syndrome, liver disease, renal failure, or an excess or deficiency of GH or cortisol
  • Medications that could affect glucose and lipid levels or the secretion of growth hormone, ghrelin, insulin, or cortisol such as rhGH, glucocorticoids, and birth control pills
  • Pregnancy
  • Smoking or substance abuse
  • Active dieting
  • Surgical procedures for obesity
  • Dietary restrictions such as bread, dairy, peanut, aspartame, or meat products used in the study
  • Metal implants, including intracranial surgical clips or pacemakers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Related Publications (4)

  • Misra M, Tsai PM, Mendes N, Miller KK, Klibanski A. Increased carbohydrate induced ghrelin secretion in obese vs. normal-weight adolescent girls. Obesity (Silver Spring). 2009 Sep;17(9):1689-95. doi: 10.1038/oby.2009.86. Epub 2009 Mar 26.

  • Misra M, Bredella MA, Tsai P, Mendes N, Miller KK, Klibanski A. Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E385-92. doi: 10.1152/ajpendo.00052.2008. Epub 2008 Jun 10.

  • Russell M, Bredella M, Tsai P, Mendes N, Miller KK, Klibanski A, Misra M. Relative growth hormone deficiency and cortisol excess are associated with increased cardiovascular risk markers in obese adolescent girls. J Clin Endocrinol Metab. 2009 Aug;94(8):2864-71. doi: 10.1210/jc.2009-0380. Epub 2009 May 12.

  • Russell M, Mendes N, Miller KK, Rosen CJ, Lee H, Klibanski A, Misra M. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab. 2010 Mar;95(3):1247-55. doi: 10.1210/jc.2009-1475. Epub 2010 Jan 15.

Related Links

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum and urine collected

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

Limited number of participants-pilot study

Results Point of Contact

Title
Madhu Misra, MD
Organization
Massachusetts General Hospital

Study Officials

  • Madhusmita Misra, MD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Pediatric Endocrinology

Study Record Dates

First Submitted

August 30, 2005

First Posted

September 1, 2005

Study Start

May 1, 2005

Primary Completion

June 1, 2007

Study Completion

June 1, 2007

Last Updated

November 2, 2021

Results First Posted

September 2, 2011

Record last verified: 2021-10

Locations